Canada Life’s Abeona Therapeutics ABEO Stock Holding History

Canada Life’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-146	Closed	-$17K	–	1113
2019 Q2	$17K	Hold	146	–	–	﹤0.01%	2597
2019 Q1	$27K	Hold	146	–	–	﹤0.01%	2342
2018 Q4	$25K	Hold	146	–	–	﹤0.01%	2512
2018 Q3	$47K	Hold	146	–	–	﹤0.01%	2408
2018 Q2	$58K	Hold	146	–	–	﹤0.01%	2369
2018 Q1	$52K	Hold	146	–	–	﹤0.01%	2355
2017 Q4	$58K	Buy	+146	New	+$60.4K	﹤0.01%	2319

Other funds holding ABEO

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Canada Life's ABEO Position: Q3 2019 in Review

Canada Life sold out of Abeona Therapeutics (ABEO) in Q3 2019, closing a stake of 146 shares — an estimated $17K sold.

Canada Life first reported a position in ABEO in Q4 2017 and held it in 7 quarters. The position peaked at $58K in Q2 2018. 79 funds tracked by Wall St. Rank hold ABEO as of Q3 2019.

Canada Life reported no remaining Abeona Therapeutics position as of Q3 2019 after selling out during the quarter.
Canada Life sold 146 Abeona Therapeutics shares in Q3 2019, an estimated $17K.
Canada Life first reported a position in Abeona Therapeutics in Q4 2017 and held it in 7 quarters.
Canada Life's Abeona Therapeutics position peaked at $58K in Q2 2018.
79 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2019.

Based on Canada Life's 13F filing for Q3 2019, filed 25 Oct 2019.